Aclaris Therapeutics, Inc. (ACRS)

NASDAQ: ACRS · Real-Time Price · USD

1.900

+0.060 (3.26%)

At close: Oct 8, 2025, 4:00 PM EDT

1.900

0.00 (0.00%)

After-hours: Oct 8, 2025, 7:18 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Therapeutics	16.18M	Log In	Log In	Log In	Log In	Upgrade
Therapeutics Growth	-42.66%	Log In	Log In	Log In	Log In	Upgrade
Contract Research	2.54M	Log In	Log In	Log In	Log In	Upgrade
Contract Research Growth	-16.28%	Log In	Log In	Log In	Log In	Upgrade
Corporate and Other	-	Log In	Log In	Log In	Log In	Upgrade
Corporate and Other Growth	-	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	18.72M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-40.09%	Log In	Log In	Log In	Log In	Upgrade